Under NICE guidance (TA664), Saxenda is available on the NHS only through specialist weight management services for people who meet specific criteria: a BMI of at least 35 kg/m (or 32.5 kg/m for people from South Asian, Chinese, Black African or African-Caribbean backgrounds) with weight-related comorbidities, and only as part of a comprehensive programme including diet, physical activity and behavioural support
Mittendorf T, Smith-Palmer J, Timlin L, Happich M, Goodall G
AndresSPevnySZiegenhagenRBakhiyaNSchferBHirsch-ErnstKIet al
Compounded tirzepatide and FDA-approved branded Zepbound are not the same product category - they have different regulatory statuses, different quality review pathways, and potentially different cost structures
The company aims to steer away from makingany health claims, products of this company are not intended to diagnose, treat, cure or prevent any disease
How Can You Buy Wegovy (Semaglutide)